[go: up one dir, main page]

MX2020006664A - Composiciones liquidas de suministro. - Google Patents

Composiciones liquidas de suministro.

Info

Publication number
MX2020006664A
MX2020006664A MX2020006664A MX2020006664A MX2020006664A MX 2020006664 A MX2020006664 A MX 2020006664A MX 2020006664 A MX2020006664 A MX 2020006664A MX 2020006664 A MX2020006664 A MX 2020006664A MX 2020006664 A MX2020006664 A MX 2020006664A
Authority
MX
Mexico
Prior art keywords
polymer
liquid supply
composition
delivery vehicle
supply compositions
Prior art date
Application number
MX2020006664A
Other languages
English (en)
Inventor
Luigi Maria Longo
Cristina Macelloni
Silvia Rossi
Franca Ferrari
Cristina Bonferoni
Giuseppina Sandri
Original Assignee
Cosmo Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cosmo Technologies Ltd filed Critical Cosmo Technologies Ltd
Publication of MX2020006664A publication Critical patent/MX2020006664A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/33—Fibroblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/006—Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0071—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form solution, solute
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Oncology (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invención proporciona una composición para usarse como vehículo de suministro que comprende al menos un polímero termosensible (polímero A) y al menos un polímero sensible a iones (polímero B) en una formulación líquida. El polímero A es preferiblemente un copolímero en bloque de polioxietileno-polioxip ropileno o un derivado de celulosa. Polímero B un polisacárido. La composición puede incluir una sustancia activa para el suministro o puede usarse como un vehículo de suministro para una sustancia agregada en el momento de la administración, tal como células madre mesenquimales.
MX2020006664A 2017-12-22 2018-12-20 Composiciones liquidas de suministro. MX2020006664A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17210119.8A EP3501496A1 (en) 2017-12-22 2017-12-22 Liquid delivery composition
PCT/EP2018/086424 WO2019122253A1 (en) 2017-12-22 2018-12-20 Liquid Delivery Composition

Publications (1)

Publication Number Publication Date
MX2020006664A true MX2020006664A (es) 2020-08-31

Family

ID=60782071

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2020006664A MX2020006664A (es) 2017-12-22 2018-12-20 Composiciones liquidas de suministro.
MX2023007117A MX2023007117A (es) 2017-12-22 2020-07-13 Formulacion liquida para preparar un vehiculo de suministro que comprende un polimero termosensible y un polimero sensible a iones.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2023007117A MX2023007117A (es) 2017-12-22 2020-07-13 Formulacion liquida para preparar un vehiculo de suministro que comprende un polimero termosensible y un polimero sensible a iones.

Country Status (14)

Country Link
US (2) US12011483B2 (es)
EP (3) EP3501496A1 (es)
JP (2) JP7494116B2 (es)
KR (2) KR20200103012A (es)
CN (1) CN111511352A (es)
BR (1) BR112020012519A2 (es)
CA (1) CA3081633A1 (es)
DK (1) DK3727453T3 (es)
ES (1) ES3031471T3 (es)
FI (1) FI3727453T3 (es)
MX (2) MX2020006664A (es)
PL (1) PL3727453T3 (es)
RU (1) RU2020124103A (es)
WO (1) WO2019122253A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4157998A4 (en) * 2020-06-02 2024-10-16 The Johns Hopkins University Gel for use in gastrointestinal endoscopy and endodermal, epidermal, and other mucosal uses
KR20230052921A (ko) * 2020-08-17 2023-04-20 휴먼웰 파마슈티컬 유에스 지속성 인-시투(in-situ) 형성/겔화 조성물
LU102338B1 (en) * 2020-12-21 2022-06-21 Luxembourg Inst Science & Tech List Medium for in vitro transportation and storage of cells
WO2023018661A1 (en) * 2021-08-10 2023-02-16 Bayer Healthcare Llc Liquid formulations comprising alginic acid, pectin, and carrageenan and methods of using thereof
WO2023018649A1 (en) * 2021-08-10 2023-02-16 Bayer Healthcare Llc Liquid formulations comprising alginic acid, pectin, and carrageenan and methods of using thereof for gastric and gastroesophageal disorders
EP4162928A1 (en) * 2021-10-05 2023-04-12 Cosmo Technologies Ltd. Rifamycin for the treatment of pouchitis, with an in-situ gelling formulation
AR127259A1 (es) * 2021-10-05 2024-01-03 Cosmo Technologies Ltd Enema gelificante in situ de rifamicina para el tratamiento de pouchitis y colitis ulcerativa distal
CN116510092A (zh) * 2023-05-19 2023-08-01 西安富丞生物科技有限公司 一种辅助内镜手术的多功能温敏型水凝胶及其制备方法
CN117362107B (zh) * 2023-10-18 2025-04-18 山东农业大学 一种含有温敏嵌段共聚物开关的包膜控释肥及其制备方法
MX2023012862A (es) * 2023-10-27 2023-11-09 Mar Mariana Guerrero Composicion topica de agentes esclerosantes en portadores acuosos.
EP4616878A1 (en) 2024-03-15 2025-09-17 Cosmo Technologies Ltd. Cannula for rectal administration of an enema and compositions for use therewith
WO2025191166A1 (en) 2024-03-15 2025-09-18 Cosmo Technologies Ltd. Cannula for rectal administration of an enema and compositions for use therewith
WO2025210108A1 (en) * 2024-04-03 2025-10-09 Orocidin A/S Composition for treatment of periodontal disease and related method

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5296236A (en) * 1988-09-16 1994-03-22 Recordati S.A., Chemical And Pharmaceutical Company Controlled release therapeutic system for a liquid pharmaceutical formulations
US5124151A (en) * 1990-08-07 1992-06-23 Mediventures Inc. Drug delivery by injection with thermo-irreversible gels
US5143731A (en) * 1990-08-07 1992-09-01 Mediventures Incorporated Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels
US6280745B1 (en) * 1997-12-23 2001-08-28 Alliance Pharmaceutical Corp. Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions
KR100509119B1 (ko) 1999-07-16 2005-08-18 주식회사 엘지생활건강 프로시아니딘 올리고머를 유효성분으로 하는 약제
JP2006225398A (ja) 2002-04-01 2006-08-31 Kaken Pharmaceut Co Ltd 塩基性線維芽細胞増殖因子含有歯科用粘稠製剤
AU2004224439B2 (en) 2003-03-24 2010-07-15 Genzyme Corporation Temporary embolization using inverse thermosensitive polymers
JP5153329B2 (ja) * 2004-07-22 2013-02-27 カムブァ、アイピー、ヴェンチュァズ、エル、ピー （ｒ／ｓ）リファマイシン誘導体、その調製、および医薬組成物
CN101137369A (zh) * 2005-02-09 2008-03-05 马库赛特公司 用于眼治疗的制剂
CN101827523A (zh) * 2007-08-16 2010-09-08 马库赛特公司 用于治疗眼部疾病或病症的制剂
AU2009205314A1 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
KR101101321B1 (ko) 2008-11-03 2012-01-02 주식회사 엠씨티티 상처 치유를 위한 하이드로 겔 형태의 세포전달용 비히클 및 그 제조방법
RU2013147883A (ru) 2011-04-01 2015-05-10 Юниверсити Оф Флорида Рисеч Фаундэйшн, Инк. Термочувствительные, мукоадгезивные или кожно-адгезивные и усиливающие проникновение композиции для местной доставки терапевтических средств
CN110693890A (zh) * 2012-02-13 2020-01-17 科斯莫科技有限公司 用于治疗呈现至少一种炎性组分的肠道疾病的方法
FR2994844B1 (fr) 2012-08-31 2015-01-02 Assist Publ Hopitaux De Paris Formulation gelifiante a base de ketamine
US10335398B2 (en) 2015-04-08 2019-07-02 Maxinase Life Sciences Limited Bioadhesive compositions for intranasal administration of granisetron
JP2018528260A (ja) 2015-07-28 2018-09-27 ビオーム バイオサイエンシズ プライベート リミティド 抗菌性治療薬及び予防薬
EP3173067B1 (en) 2015-11-16 2018-11-14 Istanbul Universitesi Rektorlugu Mucoadhesive buccal in situ gel formulation

Also Published As

Publication number Publication date
US12011483B2 (en) 2024-06-18
WO2019122253A1 (en) 2019-06-27
RU2020124103A (ru) 2022-01-24
EP3727453A1 (en) 2020-10-28
JP7494116B2 (ja) 2024-06-03
EP4574173A1 (en) 2025-06-25
FI3727453T3 (fi) 2025-07-07
CN111511352A (zh) 2020-08-07
EP3727453B1 (en) 2025-04-16
BR112020012519A2 (pt) 2021-02-23
KR20240133770A (ko) 2024-09-04
JP2021506913A (ja) 2021-02-22
DK3727453T3 (da) 2025-06-23
CA3081633A1 (en) 2019-06-27
KR20200103012A (ko) 2020-09-01
PL3727453T3 (pl) 2025-07-07
US20240299551A1 (en) 2024-09-12
EP3501496A1 (en) 2019-06-26
JP2024100934A (ja) 2024-07-26
RU2020124103A3 (es) 2022-01-24
ES3031471T3 (en) 2025-07-09
MX2023007117A (es) 2023-06-29
US20210154300A1 (en) 2021-05-27

Similar Documents

Publication Publication Date Title
MX2020006664A (es) Composiciones liquidas de suministro.
CL2019003589A1 (es) Derivado de n2,n4-difenilpirimidin-2,4-diamina, método para la preparación del mismo, y una composición farmacéutica que contiene el mismo como ingrediente activo para la prevención o tratamiento de cáncer.
CR20150523A (es) Uso de 2,3-dihidroimidazo [1,2-c]quinazolinas sustituidas
CO7151487A2 (es) Formulación de anticuerpos
CL2020001762A1 (es) Formas cristalinas del derivado de 4-pirimidinsulfamida de aprocitentán. (divisional solicitud 201902464)
MX2019005379A (es) Derivado de pirazolo-heteroarilo, metodo de preparacion y uso medico del mismo.
CL2017003436A1 (es) Compuestos de benzoxacepina oxazolidinona y métodos de uso
MX2018014906A (es) Composiciones farmaceuticas nasales con un excipiente poroso.
CL2015003442A1 (es) Derivados heterociclicos
CL2015001984A1 (es) (divisional de la sol. 1567-2013) combinaciones de principios activos que comprenden piridiletilbenzamidas y otros principios activos.
UY31079A1 (es) Derivados de fenilaminobenceno sustituidos de utilidad para el tratamiento de trastornos y enfermedades hiperproliferativos asociados con actividad quinasa extracelular mediada por mitógenos
CR20140365A (es) Compuestos de carbamato y preparación y uso de los mismos
CL2016001041A1 (es) Implante intraocular biodegradable que contiene una matriz de polimero biodegradable, polietilenglicol 3350 y una prostamida; uso del mismo en la reducción de la presion ocular en el ojo de un mamifero; aparato para administrar el implante intraocular biodegradable; y método para confeccionar un implante intraocular biodegradable.
BR112015029631A2 (pt) sistemas cirúrgicos periféricos de lente intraocular
AR095672A1 (es) Composiciones farmacéuticas que comprenden everolimus
AR088382A1 (es) Formulaciones de etanercept estabilizadas con xilitol
AR095081A1 (es) Compuestos químicos
BR112015017246A8 (pt) composição farmacêutica aquosa, seu uso e seringa
CL2020001369A1 (es) Composición adecuada para usar como agroquímico, que comprende un componente de micropartícula y un agente activo de alta potencia encapsulado en la micropartícula. (divisional solicitud 201701964)
CO2019014671A2 (es) Agentes de iarn para la inhibición de la expresión de alfa-enac y métodos de uso
BR112021017878A2 (pt) Carbonato de magnésio com superfície reagida, sistema de liberação, formulação de cuidados domiciliares, métodos para preparar um carbonato de magnésio com superfície reagida e para preparar um sistema de liberação, e, uso de um carbonato de magnésio com superfície reagida e de um sistema de liberação
CL2013002700A1 (es) Cápsula suave ingerible que contiene inositol y excipientes, o inositol, excipientes y al menos un principio activo adicional, tal como ácido fólico, polifenoles de cocoa, genisteína, l-arginina, vitamina e, selenio, n-acetilcisteína y melatonina; útil para el tratamiento del ovario poliquístico, resistencia a la insulina y otros
CL2021000998A1 (es) Agentes de liberación de gas antimicrobianos y sistemas y métodos para utilizarlos
MX2021014273A (es) Derivado de heteroarilo que contiene n y composicion farmaceutica que lo comprende como principio activo para la prevencion o el tratamiento de cancer.
MX2018004695A (es) Composiciones de proteinas estables.